title: API2-MALT1 chimeric transcript is a predictive marker for the responsiveness of H. pylori eradication treatment in low-grade gastric MALT lymphoma.
authors.forename: T
authors.initials: T
authors.lastname: Sugiyama
authors.forename: M
authors.initials: M
authors.lastname: Asaka
authors.forename: T
authors.initials: T
authors.lastname: Nakamura
authors.forename: S
authors.initials: S
authors.lastname: Nakamura
authors.forename: S
authors.initials: S
authors.lastname: Yonezumi
authors.forename: M
authors.initials: M
authors.lastname: Seto
mesh_terms: D015415:Biomarkers; D005260:Female; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000382:microbiology*; D008228:Lymphoma, Non-Hodgkin / Q000382:microbiology*; D008297:Male; D008875:Middle Aged; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D012333:RNA, Messenger / Q000032:analysis*; D013274:Stomach Neoplasms / Q000382:microbiology*
chemical_list: C415943:API2-MALT1 fusion protein, human; D015415:Biomarkers; D015514:Oncogene Proteins, Fusion; D012333:RNA, Messenger